Literature DB >> 17256126

Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats.

Małgorzata Filip1, Małgorzata Frankowska, Magdalena Zaniewska, Anna Gołda, Edmund Przegaliński, Jerzy Vetulani.   

Abstract

RATIONALE: Recent data indicate that gamma-aminobutyric acid (GABA) is a modulator of behavioral responses to cocaine.
OBJECTIVE: The efficacy of gabapentin (a cyclic GABA analogue), tiagabine (a GABA reuptake inhibitor), or vigabatrin (an inhibitor of GABA transaminase and reuptake) to alter cocaine-seeking behavior and discriminative effects was examined in rats.
MATERIALS AND METHODS: Rats were trained to press a lever for cocaine (0.5 mg/kg per infusion) paired with a cue (light + tone) using a fixed ratio (FR) 5 schedule of reinforcement. After extinction, the cocaine-seeking behavior was reinstated by cocaine priming (10 mg/kg). Another group of rats was trained to discriminate cocaine (10 mg/kg) from saline in a two-lever FR 20 task.
RESULTS: Vigabatrin (150-250 mg/kg) decreased cocaine-maintained responding, whereas tiagabine (10 mg/kg) significantly reduced responses on the "active" lever. Vigabatrin (150-250 mg/kg) significantly decreased responding to the cocaine-priming dose and a nonsignificant attenuation of cocaine-induced reinstatement was seen after tiagabine (5-10 mg/kg). Gabapentin (10-30 mg/kg) failed to alter maintenance of cocaine self-administration or drug-induced reinstatement. Pretreatment with either gabapentin, tiagabine, or vigabatrin resulted in neither reinstatement of cocaine seeking nor alterations in cocaine discrimination.
CONCLUSIONS: Our study demonstrates that vigabatrin (only at the 150 mg/kg dose) exerted inhibitory actions on cocaine-maintained responding and attenuated the reinstatement of extinguishing responding more effectively than gabapentin or tiagabine and with less evidence of motor impairment than the latter drugs. Present findings do not support a role for gabapentin or tiagabine for the possible treatment of cocaine relapse, whereas albeit limited effects of vigabatrin may be seen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256126     DOI: 10.1007/s00213-006-0694-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Effects of GABAergic modulators on food and cocaine self-administration in baboons.

Authors:  Elise M Weerts; Wolfgang Froestl; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2005-07-07       Impact factor: 4.492

Review 2.  The pharmacology of GABA-transaminase inhibitors.

Authors:  M G Palfreyman; P J Schechter; W R Buckett; G P Tell; J Koch-Weser
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

3.  Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.

Authors:  U Schmitt; C Hiemke
Journal:  Behav Pharmacol       Date:  1999-03       Impact factor: 2.293

4.  Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats.

Authors:  Eliot L Gardner; Wynne K Schiffer; Bryan A Horan; David Highfield; Stephen L Dewey; Jonathan D Brodie; Charles R Ashby
Journal:  Synapse       Date:  2002-12-15       Impact factor: 2.562

5.  Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats.

Authors:  P Munzar; S W Kutkat; C R Miller; S R Goldberg
Journal:  Eur J Pharmacol       Date:  2000-11-17       Impact factor: 4.432

6.  Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats.

Authors:  Andrew C Barrett; S Stevens Negus; Nancy K Mello; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2005-07-20       Impact factor: 4.030

7.  Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Drug Alcohol Depend       Date:  2004-10-05       Impact factor: 4.492

8.  The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

Authors:  A Fink-Jensen; P D Suzdak; M D Swedberg; M E Judge; L Hansen; P G Nielsen
Journal:  Eur J Pharmacol       Date:  1992-09-22       Impact factor: 4.432

9.  Gabapentin reduces cocaine use among addicts from a community clinic sample.

Authors:  Wilfrid Noel Raby; Siobhan Coomaraswamy
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

10.  Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans.

Authors:  Carl L Hart; Amie S Ward; Eric D Collins; Margaret Haney; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2004-03-08       Impact factor: 4.492

View more
  13 in total

1.  Persistent reduction of cocaine seeking by pharmacological manipulation of adenosine A1 and A 2A receptors during extinction training in rats.

Authors:  Casey E O'Neill; Benjamin D Hobson; Sophia C Levis; Ryan K Bachtell
Journal:  Psychopharmacology (Berl)       Date:  2014-02-23       Impact factor: 4.530

2.  α2δ-1 signaling in nucleus accumbens is necessary for cocaine-induced relapse.

Authors:  Sade Spencer; Robyn M Brown; Gabriel C Quintero; Yonatan M Kupchik; Charles A Thomas; Kathryn J Reissner; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

Review 3.  Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

4.  Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats.

Authors:  Xiao-Qing Peng; Xia Li; Jie Li; P Veeraraghavan Ramachandran; Pravin D Gagare; Debarshi Pratihar; Charles R Ashby; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

Review 5.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

Review 6.  Anti-relapse medications: preclinical models for drug addiction treatment.

Authors:  Noushin Yahyavi-Firouz-Abadi; Ronald E See
Journal:  Pharmacol Ther       Date:  2009-08-13       Impact factor: 12.310

7.  (-)-Trans-Δ9-Tetrahydrocannabinol-Like Discriminative-Stimulus Effects of Gabapentin in Cannabis Users.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2016-02-10

8.  Gastrodia Elata Bl Attenuates Cocaine-Induced Conditioned Place Preference and Convulsion, but not Behavioral Sensitization in Mice: Importance of GABA(A) Receptors.

Authors:  E-J Shin; J-H Bach; T-T L Nguyen; B-D Jung; K-W Oh; M J Kim; C G Jang; S F Ali; S K Ko; C H Yang; H-C Kim
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

9.  Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats.

Authors:  Joyce Besheer; Suzanne Frisbee; Patrick A Randall; Anel A Jaramillo; Maria Masciello
Journal:  Neuropharmacology       Date:  2015-09-28       Impact factor: 5.250

Review 10.  Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Authors:  B Jupp; J W Dalley
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.